Viewing Study NCT01493557


Ignite Creation Date: 2025-12-24 @ 6:37 PM
Ignite Modification Date: 2026-02-26 @ 4:18 PM
Study NCT ID: NCT01493557
Status: COMPLETED
Last Update Posted: 2015-10-05
First Post: 2011-12-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-12
Start Date Type: None
Primary Completion Date: 2014-07
Primary Completion Date Type: ACTUAL
Completion Date: 2014-07
Completion Date Type: ACTUAL
First Submit Date: 2011-12-12
First Submit QC Date: None
Study First Post Date: 2011-12-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-07-06
Results First Submit QC Date: None
Results First Post Date: 2015-10-05
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-09-02
Last Update Post Date: 2015-10-05
Last Update Post Date Type: ESTIMATED